Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
1.
Radiat Res ; 193(5): 451-459, 2020 05.
Article in English | MEDLINE | ID: mdl-32150497

ABSTRACT

Findings from previous studies have suggested that the telomerase system is involved in radiation-induced genomic instability. In this study, we investigated the involvement of telomerase in the development and processing of chromosomal damage at different cell cycle stages after irradiation of human fibroblasts. Several response criteria were investigated, including cell survival, chromosomal damage (using the micronucleus assay), G2-induced chromatid aberrations (using the conventional G2 assay as well as a chemically-induced premature chromosome condensation assay) and DNA double-strand breaks (DSBs; using γ-H2AX, 53BP1 and Rad51) in an isogenic pair of cell lines: BJ human foreskin fibroblasts and BJ1-hTERT, a telomerase-immortalized BJ cell line. To distinguish among G1, S and G2 phase, cells were co-immunostained for CENP-F and cyclin A, which are tightly regulated proteins in the cell cycle. After X-ray irradiation at doses in the range of 0.1-6 Gy, the results showed that for cell survival and micronuclei induction, where the overall effect is dominated by the cells in G1 and S phase, no difference was observed between the two cell types; in contrast, when radiation sensitivity at the G2 stage of the cell cycle was analyzed, a significantly higher number of chromatid-type aberrations (breaks and exchanges), and higher levels of γ-H2AX and of Rad51 foci were observed for the BJ cells compared to the BJ1-hTERT cells. Therefore, it can be concluded that telomerase appears to be involved in DNA DSB repair processes, mainly in the G2 phase. These data, taken overall, reinforce the notion that hTERT or other elements of the telomere/telomerase system may defend chromosome integrity in human fibroblasts by promoting repair in G2 phase of the cell cycle.


Subject(s)
Genomic Instability/radiation effects , Telomerase/metabolism , Cell Line , Cell Survival/radiation effects , Fibroblasts/cytology , Fibroblasts/metabolism , Fibroblasts/radiation effects , G2 Phase/radiation effects , Gamma Rays/adverse effects , Humans , Micronucleus Tests , Rad51 Recombinase/metabolism , S Phase/radiation effects
2.
Int J Radiat Biol ; 93(1): 30-35, 2017 01.
Article in English | MEDLINE | ID: mdl-27705052

ABSTRACT

PURPOSE: In the framework of RENEB, several biodosimetry exercises were conducted analyzing different endpoints. Among them, the analysis of translocations is considered the most useful method for retrospective biodosimetry due to the relative stability of their frequency with post irradiation time. The aim of this study was to harmonize the accuracy of translocation-based biodosimetry within the RENEB consortium. MATERIALS AND METHODS: An initial telescoring exercise analyzing FISH metaphase images was done to harmonize chromosome aberration descriptions. Then two blind intercomparison exercises (IE) were performed, by sending irradiated blood samples to each partner. Samples were cultured and stained by each partner using their standard protocol and translocation frequency was used to produce dose estimates. RESULTS: The coefficient of variation in the 1st IE (CV = 0.34) was higher than in the 2nd IE (CV = 0.16 and 0.23 in the two samples analyzed), for the genomic frequency of total translocations. Z-score analysis revealed that eight out of 10 and 17 out of 20 dose estimates were satisfactory in the 1st and 2nd IE, respectively. CONCLUSIONS: The results obtained indicate that, despite the problems identified in few partners, which can be corrected, the RENEB consortium is able to carry out retrospective biodosimetry analyzing the frequency of translocations by FISH.


Subject(s)
Biological Assay/methods , In Situ Hybridization, Fluorescence/methods , Quality Assurance, Health Care , Radiation Exposure/analysis , Radiation Monitoring/methods , Translocation, Genetic/radiation effects , Biological Assay/standards , Europe , Humans , In Situ Hybridization, Fluorescence/standards , Lymphocytes/radiation effects , Radiation Monitoring/standards , Reproducibility of Results , Sensitivity and Specificity , Translocation, Genetic/genetics
3.
Int J Radiat Biol ; 93(1): 36-47, 2017 01.
Article in English | MEDLINE | ID: mdl-27673504

ABSTRACT

PURPOSE: In the framework of the 'Realizing the European Network of Biodosimetry' (RENEB) project, two intercomparison exercises were conducted to assess the suitability of an optimized version of the cytokinesis-block micronucleus assay, and to evaluate the capacity of a large laboratory network performing biodosimetry for radiation emergency triages. Twelve European institutions participated in the first exercise, and four non-RENEB labs were added in the second one. MATERIALS AND METHODS: Irradiated blood samples were shipped to participating labs, whose task was to culture these samples and provide a blind dose estimate. Micronucleus analysis was performed by automated, semi-automated and manual procedures. RESULTS: The dose estimates provided by network laboratories were in good agreement with true administered doses. The most accurate estimates were reported for low dose points (≤ 0.94 Gy). For higher dose points (≥ 2.7 Gy) a larger variation in estimates was observed, though in the second exercise the number of acceptable estimates increased satisfactorily. Higher accuracy was achieved with the semi-automated method. CONCLUSION: The results of the two exercises performed by our network demonstrate that the micronucleus assay is a useful tool for large-scale radiation emergencies, and can be successfully implemented within a large network of laboratories.


Subject(s)
Biological Assay/methods , Chromosome Aberrations/radiation effects , Micronucleus Tests/methods , Quality Assurance, Health Care , Radiation Exposure/analysis , Radiation Monitoring/methods , Biological Assay/standards , Europe , Humans , Lymphocytes/radiation effects , Radiation Monitoring/standards , Reproducibility of Results , Sensitivity and Specificity
4.
Int J Radiat Biol ; 93(1): 48-57, 2017 01.
Article in English | MEDLINE | ID: mdl-27813725

ABSTRACT

PURPOSE: Dose assessment intercomparisons within the RENEB network were performed for triage biodosimetry analyzing G0-lymphocyte PCC for harmonization, standardization and optimization of the PCC assay. MATERIALS AND METHODS: Comparative analysis among different partners for dose assessment included shipment of PCC-slides and captured images to construct dose-response curves for up to 6 Gy γ-rays. Accident simulation exercises were performed to assess the suitability of the PCC assay by detecting speed of analysis and minimum number of cells required for categorization of potentially exposed individuals. RESULTS: Calibration data based on Giemsa-stained fragments in excess of 46 PCC were obtained by different partners using galleries of PCC images for each dose-point. Mean values derived from all scores yielded a linear dose-response with approximately 4 excess-fragments/cell/Gy. To unify scoring criteria, exercises were carried out using coded PCC-slides and/or coded irradiated blood samples. Analysis of samples received 24 h post-exposure was successfully performed using Giemsa staining (1 excess-fragment/cell/Gy) or centromere/telomere FISH-staining for dicentrics. CONCLUSIONS: Dose assessments by RENEB partners using appropriate calibration curves were mostly in good agreement. The PCC assay is quick and reliable for whole- or partial-body triage biodosimetry by scoring excess-fragments or dicentrics in G0-lymphocytes. Particularly, analysis of Giemsa-stained excess PCC-fragments is simple, inexpensive and its automation could increase throughput and scoring objectivity of the PCC assay.


Subject(s)
Biological Assay/methods , Chromosome Aberrations/radiation effects , Micronucleus Tests/methods , Quality Assurance, Health Care , Radiation Exposure/analysis , Radiation Monitoring/methods , Biological Assay/standards , Europe , Humans , Lymphocytes/cytology , Lymphocytes/radiation effects , Radiation Monitoring/standards , Reproducibility of Results , Resting Phase, Cell Cycle/genetics , Resting Phase, Cell Cycle/radiation effects , Sensitivity and Specificity
5.
Environ Res ; 150: 191-204, 2016 10.
Article in English | MEDLINE | ID: mdl-27295409

ABSTRACT

This review contends that "healthy" water in terms of electrolyte balance is as important as "pure" water in promoting public health. It considers the growing use of desalination (demineralization) technologies in drinking water treatment which often results in tap water with very low concentrations of sodium, potassium, magnesium and calcium. Ingestion of such water can lead to electrolyte abnormalities marked by hyponatremia, hypokalemia, hypomagnesemia and hypocalcemia which are among the most common and recognizable features in cancer patients. The causal relationships between exposure to demineralized water and malignancies are poorly understood. This review highlights some of the epidemiological and in vivo evidence that link dysregulated electrolyte metabolism with carcinogenesis and the development of cancer hallmarks. It discusses how ingestion of demineralized water can have a procarcinogenic effect through mediating some of the critical pathways and processes in the cancer microenvironment such as angiogenesis, genomic instability, resistance to programmed cell death, sustained proliferative signaling, cell immortalization and tumorigenic inflammation. Evidence that hypoosmotic stress-response processes can upregulate a number of potential oncogenes is well supported by a number studies. In view of the rising production and consumption of demineralized water in most parts of the world, there is a strong need for further research on the biological importance and protean roles of electrolyte abnormalities in promoting, antagonizing or otherwise enabling the development of cancer. The countries of the Gulf Cooperative Council (GCC) where most people consume desalinated water would be a logical place to start this research.


Subject(s)
Carcinogenesis , Drinking Water/adverse effects , Electrolytes/adverse effects , Neoplasms/epidemiology , Water Purification , Water-Electrolyte Imbalance/epidemiology , Electrolytes/metabolism , Neoplasms/chemically induced , Water-Electrolyte Imbalance/chemically induced
6.
Radiat Environ Biophys ; 54(4): 445-51, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26319788

ABSTRACT

The aim of this study was to apply the fluorescence in situ hybridization (FISH) translocation assay in combination with chromosome painting of peripheral blood lymphocytes for retrospective biological dosimetry of Mayak nuclear power plant workers exposed chronically to external gamma radiation. These data were compared with physical dose estimates based on monitoring with badge dosimeters throughout each person's working life. Chromosome translocation yields for 94 workers of the Mayak production association were measured in three laboratories: Southern Urals Biophysics Institute, Leiden University Medical Center and the former Health Protection Agency of the UK (hereinafter Public Health England). The results of the study demonstrated that the FISH-based translocation assay in workers with prolonged (chronic) occupational gamma-ray exposure was a reliable biological dosimeter even many years after radiation exposure. Cytogenetic estimates of red bone marrow doses from external gamma rays were reasonably consistent with dose measurements based on film badge readings successfully validated in dosimetry system "Doses-2005" by FISH, within the bounds of the associated uncertainties.


Subject(s)
Biological Assay/methods , Chromosome Aberrations/radiation effects , In Situ Hybridization, Fluorescence , Lymphocytes/physiology , Occupational Exposure/analysis , Radiation Exposure/analysis , Absorption, Radiation , Aged , Chromosome Painting , Female , Gamma Rays , Humans , Lymphocytes/radiation effects , Male , Radioactive Hazard Release , Reproducibility of Results , Sensitivity and Specificity , Translocation, Genetic/radiation effects , Whole-Body Counting
7.
Carcinogenesis ; 36 Suppl 1: S61-88, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26106144

ABSTRACT

Genome instability is a prerequisite for the development of cancer. It occurs when genome maintenance systems fail to safeguard the genome's integrity, whether as a consequence of inherited defects or induced via exposure to environmental agents (chemicals, biological agents and radiation). Thus, genome instability can be defined as an enhanced tendency for the genome to acquire mutations; ranging from changes to the nucleotide sequence to chromosomal gain, rearrangements or loss. This review raises the hypothesis that in addition to known human carcinogens, exposure to low dose of other chemicals present in our modern society could contribute to carcinogenesis by indirectly affecting genome stability. The selected chemicals with their mechanisms of action proposed to indirectly contribute to genome instability are: heavy metals (DNA repair, epigenetic modification, DNA damage signaling, telomere length), acrylamide (DNA repair, chromosome segregation), bisphenol A (epigenetic modification, DNA damage signaling, mitochondrial function, chromosome segregation), benomyl (chromosome segregation), quinones (epigenetic modification) and nano-sized particles (epigenetic pathways, mitochondrial function, chromosome segregation, telomere length). The purpose of this review is to describe the crucial aspects of genome instability, to outline the ways in which environmental chemicals can affect this cancer hallmark and to identify candidate chemicals for further study. The overall aim is to make scientists aware of the increasing need to unravel the underlying mechanisms via which chemicals at low doses can induce genome instability and thus promote carcinogenesis.


Subject(s)
Carcinogenesis/chemically induced , Carcinogens, Environmental/adverse effects , Environmental Exposure/adverse effects , Genomic Instability/drug effects , Hazardous Substances/adverse effects , Neoplasms/chemically induced , Neoplasms/etiology , Animals , Humans
8.
Carcinogenesis ; 36 Suppl 1: S254-96, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26106142

ABSTRACT

Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide, but credible estimates from the World Health Organization and the International Agency for Research on Cancer (IARC) suggest that the fraction of cancers attributable to toxic environmental exposures is between 7% and 19%. To explore the hypothesis that low-dose exposures to mixtures of chemicals in the environment may be combining to contribute to environmental carcinogenesis, we reviewed 11 hallmark phenotypes of cancer, multiple priority target sites for disruption in each area and prototypical chemical disruptors for all targets, this included dose-response characterizations, evidence of low-dose effects and cross-hallmark effects for all targets and chemicals. In total, 85 examples of chemicals were reviewed for actions on key pathways/mechanisms related to carcinogenesis. Only 15% (13/85) were found to have evidence of a dose-response threshold, whereas 59% (50/85) exerted low-dose effects. No dose-response information was found for the remaining 26% (22/85). Our analysis suggests that the cumulative effects of individual (non-carcinogenic) chemicals acting on different pathways, and a variety of related systems, organs, tissues and cells could plausibly conspire to produce carcinogenic synergies. Additional basic research on carcinogenesis and research focused on low-dose effects of chemical mixtures needs to be rigorously pursued before the merits of this hypothesis can be further advanced. However, the structure of the World Health Organization International Programme on Chemical Safety 'Mode of Action' framework should be revisited as it has inherent weaknesses that are not fully aligned with our current understanding of cancer biology.


Subject(s)
Carcinogenesis/chemically induced , Carcinogens, Environmental/adverse effects , Environmental Exposure/adverse effects , Hazardous Substances/adverse effects , Neoplasms/chemically induced , Neoplasms/etiology , Animals , Humans
9.
Health Phys ; 108(3): 371-6, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25627950

ABSTRACT

The dicentric chromosome assay (DCA) has been regarded as the gold standard of radiation biodosimetry. The assay, however, requires a 2-d peripheral blood lymphocyte culture before starting metaphase chromosome analyses to estimate biological doses. Other biological assays also have drawbacks with respect to the time needed to obtain dose estimates for rapid decision on the correct line of medical treatment. Therefore, alternative technologies that suit requirements for triage biodosimetry are needed. Radiation-induced DNA double strand breaks in G0 lymphocytes can be detected as interphase chromosome aberrations by the cell fusion-mediated premature chromosome condensation (PCC) method. The method, in combination with fluorescence in situ hybridization (FISH) techniques, has been proposed in early studies as a powerful tool for obtaining biological dose estimates without 2-d lymphocyte culture procedures. The present work assesses the applicability of FISH-based PCC techniques using pan-centromeric and telomeric peptide nucleic acid (PNA) probes in triage mode biodosimetry and demonstrates that an improved rapid procedure of the prematurely condensed dicentric chromosome (PCDC) assay has the potential for evaluating exposed radiation doses in as short as 6 h after the collection of peripheral blood specimens.


Subject(s)
Chromosome Aberrations/radiation effects , In Situ Hybridization, Fluorescence/methods , Radiometry/methods , Triage/methods , Adult , Female , Humans , Time Factors
10.
Radiat Prot Dosimetry ; 159(1-4): 20-5, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24925900

ABSTRACT

In order to understand the potential health effect of radiation from Fukushima nuclear disaster, a group of people living in Japan during and after the accident were investigated 1 y after the accident. The venous blood samples were extracted in tune from 156 tested persons living in Tokyo and Niigata with average age of 42.4 ± 10.2 y old as well as 87 controls living in Beijing with similar age and sex proportion. Conventional chromosome culture and cytochalasin B micronucleus methods were applied. The unstable chromosome aberrations of 200 cells and micronuclei (MN) and micronuclei cells (MNC) of 1000 binucleated lymphocytes were analysed for each examined subject. The results showed that the frequencies ± SE (×100) of the dicentrics plus rings were 0.17 ± 0.024% and 0.13 ± 0.028% in the tested and control populations (p > 0.05), respectively. The frequencies of the extra acentrics were 0.21 ± 0.026% and 0.06 ± 0.018% in the tested and control groups (p < 0.01), respectively. The total chromosomal aberration frequencies of the tested and control groups were 0.40 ± 0.036% and 0.20 ± 0.034% (p < 0.01), respectively. The MN and MNC frequencies of the tested group were 29.25 ± 3.96 ‰ and 23.85 ± 4.23 ‰, and 25.30 ± 6.45 ‰ and 21.56 ± 3.99 ‰ for control group (p < 0.01). With the exception of dicentrics, there were significant differences (p < 0.01) between two groups in frequencies of chromosome aberration and MN. Generally, 1 y after the Fukushima nuclear accident, the dicentric frequencies had not increased in the 156 persons investigated in this study. The increase in chromatid aberrations, chromosomal acentrics and MN was induced but could not be directly linked to radiation exposures, as an excess of dicentric frequency is linked. However, the observed higher frequency of chromosomal alterations might be related to exposure to the low doses of ionising in this cohort. Consequently, it is recommended to assess the long-term health effects in this population.


Subject(s)
Chromosome Aberrations/radiation effects , Cytogenetic Analysis/methods , Fukushima Nuclear Accident , Lymphocytes/radiation effects , Occupational Exposure/analysis , Radiation Injuries/diagnosis , Adult , Case-Control Studies , Cohort Studies , Dose-Response Relationship, Radiation , Female , Humans , Male , Micronucleus Tests , Middle Aged , Occupational Exposure/adverse effects , Radiation Injuries/etiology , Radiation, Ionizing , Risk Assessment , Tokyo , Young Adult
12.
Radiat Prot Dosimetry ; 159(1-4): 26-33, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24736296

ABSTRACT

The fluorescence in situ hybridisation (FISH) technique is now well established for retrospective dosimetry in cases of external radiation exposure that occurred many years ago. However, the question remains as to whether FISH provides valid estimates of cumulative red bone marrow radiation doses in cases of incorporation of radionuclides or combined external and internal exposures. This question has arisen in connection with the interpretation of results of dose assessments for epidemiological studies of plutonium workers at the Russian Mayak plant and of members of the public exposed to strontium radioisotopes and external radiation as a result of discharges from Mayak to the Techa River. Exposures to penetrating external radiation result in fairly uniform irradiation of body tissues, and hence similar doses to all tissues, for which FISH dosimetry can provide a reliable measure of this whole body dose. However, intakes of radionuclides into the body by inhalation or ingestion may result in retention in specific organs and tissues, so that the distribution of dose is highly heterogeneous. For radionuclides emitting short-range radiations (e.g. alpha particles), this heterogeneity can apply to dose delivery within tissues and between cells within tissues. In this paper, an attempt is made to address the question of what FISH measures in such circumstances by considering evidence regarding the origin and lifetime dynamics of lymphocyte subsets in the human body in relation to the localised delivery of dose from the internal emitters (90)Sr and (239)Pu, which are of particular interest for the Southern Urals Mayak and Techa River populations, and for which most evidence is available in these populations. It is concluded that the FISH translocation assay can be usefully applied for detecting internal and combined external gamma and internal doses from internally deposited (90)Sr, albeit with fairly large uncertainties. The same may be true of (239)Pu, as well as other radionuclides, although much work remains to be done to establish dose-response relationships.


Subject(s)
In Situ Hybridization, Fluorescence/methods , Lymphocytes/radiation effects , Plutonium/analysis , Radiation Monitoring/methods , Strontium Radioisotopes/analysis , Translocation, Genetic/genetics , Humans , Radiation Dosage , Relative Biological Effectiveness , Rural Population , Russia , Translocation, Genetic/radiation effects
13.
Radiat Prot Dosimetry ; 159(1-4): 34-7, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24743760

ABSTRACT

Fluorescent in situ hybridisation analysis of stable translocations was performed for 26 residents living along the Techa River (Russia), who were predominantly (95%) exposed to ingested strontium radioisotopes ((89)Sr and (90)Sr) resulting in exposure of their red bone marrow (RBM). Analysis was conducted at the Urals Research Center for Radiation Medicine, Public Health England and Leiden University Medical Center. Each laboratory scored 1000 cells per donor, which resulted in ∼1000 genome equivalents (GE) per donor. The age-dependent spontaneous level of translocations for each donor was evaluated on the basis of data published by Sigurdson et al. (International study of factors affecting human chromosome. Mutat. Res. 2008;652: :112-121). Reconstruction of doses was performed with the 'Techa River Dosimetry System' developed in 2009. In the studied donors, the range of individual cumulated RBM dose was from 0.3 to 3.7 Gy. Analysis of the yield of stable translocations dependent on the individual RBM dose from (89,90)Sr showed a linear dose-response relationship of 0.007 ± 0.002 translocation/GE cell/Gy (R = 0.61, p = 0.001). This set of results was in a good agreement with the previous data reported for 18 donors by Vozilova et al. (Preliminary FISH-based assessment of external dose for residents exposed on the Techa River.


Subject(s)
Bone Marrow/radiation effects , In Situ Hybridization, Fluorescence/methods , Radiation Monitoring/methods , Strontium Radioisotopes/adverse effects , Translocation, Genetic/genetics , Translocation, Genetic/radiation effects , Aged , Humans , Middle Aged , Radiation Dosage , Relative Biological Effectiveness , Rural Population , Russia , Strontium Radioisotopes/analysis
14.
Organogenesis ; 10(1): 44-52, 2014 Jan 01.
Article in English | MEDLINE | ID: mdl-24418910

ABSTRACT

Bell shaped nuclei of metakaryotic cells double their DNA content during and after symmetric and asymmetric amitotic fissions rather than in the separate, pre-mitotic S-phase of eukaryotic cells. A parsimonious hypothesis was tested that the two anti-parallel strands of each chromatid DNA helix were first segregated as ssDNA-containing complexes into sister nuclei then copied to recreate a dsDNA genome. Metakaryotic nuclei that were treated during amitosis with RNase A and stained with acridine orange or fluorescent antibody to ssDNA revealed large amounts of ssDNA. Without RNase treatment metakaryotic nuclei in amitosis stained strongly with an antibody complex specific to dsRNA/DNA. Images of amitotic figures co-stained with dsRNA/DNA antibody and DAPI indicated that the entire interphase dsDNA genome (B-form helices) was transformed into two dsRNA/DNA genomes (A-form helices) that were segregated in the daughter cell nuclei then retransformed into dsDNA. As this process segregates DNA strands of opposite polarity in sister cells it hypothetically offers a sequential switching mechanism within the diverging stem cell lineages of development.


Subject(s)
Cell Nucleus/genetics , Chromosome Segregation , DNA Replication , DNA/metabolism , Genome , RNA/metabolism , Cell Line, Tumor , Fluorescein-5-isothiocyanate/chemistry , Humans , Immunohistochemistry , Karyotype , Stem Cells/cytology
15.
Mutat Res ; 749(1-2): 53-9, 2012 Dec 12.
Article in English | MEDLINE | ID: mdl-22944079

ABSTRACT

In this study we implemented a new assay using a nested real-time polymerase chain reaction (PCR) to detect radiation-induced common deletion (CD) in mitochondrial DNA (mtDNA) of human peripheral lymphocytes. A standard curve for real-time PCR was established by applying a plasmid DNA containing human normal mtDNA or mutated mtDNA. Human peripheral lymphocyte DNA was amplified and quantified by real-time PCR using primer sets for total damaged or mutated mtDNA, plus probes labeled with the fluorescent dyes. The first-round PCR generated multiple products were used as the template for a second-round PCR. We herein describe a nested real-time PCR assay capable of quantifying mtDNA bearing the CD in human peripheral lymphocytes following exposure (in vitro) to (137)Cs γ-rays in a dose range of 0.5 up to 5Gy. The reproducibility of this assay was evident for both unirradiated and irradiated samples by examining human blood lymphocytes from 14 donors. This technique was sensitive enough to detect deletions in mtDNA at low dose levels, as low as 0.5Gy, and higher levels of CD mtDNA were evident at higher doses (≥1Gy), however, there was no consistent dose-response relationship.


Subject(s)
DNA, Mitochondrial/radiation effects , Real-Time Polymerase Chain Reaction , Sequence Deletion , DNA, Mitochondrial/blood , Humans , Lymphocytes/chemistry , Sensitivity and Specificity
16.
J Exp Clin Cancer Res ; 30: 29, 2011 Mar 14.
Article in English | MEDLINE | ID: mdl-21401934

ABSTRACT

BACKGROUND: Ovarian cancer remains the leading cause of death from gynaecological malignancy. More than 60% of the patients are presenting the disease in stage III or IV. In spite of combination of chemotherapy and surgery the prognosis stays poor for therapy regimen. METHODS: The leaves of a plant endemic to Australia, Calomeria amaranthoides, were extracted and then fractionated by column chromatography. In vitro cytotoxicity tests were performed with fractions of the plant extract and later with an isolated compound on ovarian cancer cell lines, as well as normal fibroblasts at concentrations of 1-100 µg/mL (crude extract) and 1-10 µg/mL (compound). Cytotoxicity was measured after 24, 48 and 72 hours by using a non-fluorescent substrate, Alamar blue.In vivo cytotoxicity was tested on ascites, developed in the abdomen of nude mice after inoculation with human OVCAR3 cells intraperitoneally. The rate of change in abdomen size for the mice was determined by linear regression and statistically evaluated for significance by the unpaired t test. RESULTS: Two compounds were isolated by chromatographic fractionation and identified by 1H-NMR, 13C-NMR and mass spectrometry analyses, EPD, an α-methylene sesquiterpene lactone of the eremophilanolide subtype, and EPA, an α-methylene carboxylic acid.Cytotoxicity of EPD for normal fibroblasts at all time points IC50 was greater than 10 µg/mL, whereas, for OVCAR3 cells at 48 hours IC50 was 5.3 µg/mL (95% confidence interval 4.3 to 6.5 µg/mL).Both, the crude plant extract as well as EPD killed the cancer cells at a final concentration of 10 µg/mL and 5 µg/mL respectively, while in normal cells only 20% cell killing effect was observed. EPA had no cytotoxic effects.Changes in abdomen size for control versus Cisplatin treated mice were significantly different, P = 0.023, as were control versus EPD treated mice, P = 0.025, whereas, EPD versus Cisplatin treated mice were not significantly different, P = 0.13. CONCLUSIONS: For the first time both crude plant extract from Calomeria amaranthoides and EPD have been shown to have potent anti-cancer effects against ovarian cancer.


Subject(s)
Acrylates/therapeutic use , Antineoplastic Agents/therapeutic use , Asteraceae/chemistry , Lactones/therapeutic use , Ovarian Neoplasms/drug therapy , Plant Extracts/therapeutic use , Sesquiterpenes/therapeutic use , Acrylates/chemistry , Animals , Antineoplastic Agents/chemistry , Australia , Cell Line, Tumor , Cell Survival/drug effects , Cisplatin/therapeutic use , Female , Humans , Lactones/chemistry , Mice , Mice, Nude , Oxazines , Plant Extracts/chemistry , Sesquiterpenes/chemistry , Xanthenes
17.
Cancer Genet Cytogenet ; 203(2): 203-8, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21156234

ABSTRACT

Metakaryotic cells and syncytia with large, hollow, bell-shaped nuclei demonstrate symmetrical and asymmetrical amitotic nuclear fissions in microanatomical positions and numbers expected of stem cell lineages in tissues of all three primordial germ layers and their derived tumors. Using fluorescence in situ hybridization, mononuclear metakaryotic interphase cells have been found with only 23 centromeric and 23 telomeric staining regions. Syncytial bell-shaped nuclei found approximately during weeks 5-12 of human gestation display 23 centromeric and either 23 or 46 telomeric staining regions. These images suggest that (1) homologous chromatids pair at centromeres and telomeres, (2) all paired telomeres join end-to-end with other paired telomeres in all mononuclear and some syncytial metakaryotic cells, and (3) telomere junctions may open and close during the syncytial phase of development. Twenty-three telomeric joining figures could be accounted by 23 rings of one chromatid pair each, a single pangenomic ring of 23 joined chromatid pairs, or any of many possible sets of oligo-chromatid pair rings. As telomeric end-joining may affect peri-telomeric gene expression, a programmed sequence of telomeric end-joining associations in metakaryotic stem cells could guide developmental arboration and errors in, or interruptions of, this program could contribute to carcinogenesis.


Subject(s)
Chromatids/ultrastructure , Cytogenetics , Fetal Stem Cells/cytology , Stem Cells/cytology , Telomere/ultrastructure , Cell Nucleus/metabolism , Centromere/ultrastructure , Chromosome Mapping , Coloring Agents/chemistry , Genome , Humans , Image Cytometry/methods , In Situ Hybridization, Fluorescence/methods , Interphase , Time Factors
18.
DNA Repair (Amst) ; 9(4): 365-73, 2010 Apr 04.
Article in English | MEDLINE | ID: mdl-20079696

ABSTRACT

V(D)J rearrangement in lymphoid cells involves repair of double-strand breaks (DSBs) through non-homologous end joining (NHEJ). Defects in this process lead to increased radiosensitivity and severe combined immunodeficiency (RS-SCID). Here, a SCID patient, M3, is described with a T(-)B(+)NK(+) phenotype but without causative mutations in CD3delta, epsilon, zeta or IL7Ralpha, genes specifically involved in T cell development. Clonogenic survival of M3 fibroblasts showed an increased sensitivity to the DSB-inducing agents ionizing radiation and bleomycin, as well as the crosslinking compound, mitomycin C. We did not observe inactivating mutations in known NHEJ genes and results of various DSB-repair assays in G(1) M3 cells were indistinguishable from those obtained with normal cells. However, we found increased chromosomal radiosensitivity at the G(2) phase of the cell cycle. Checkpoint analysis indicated functional G(1)/S and intra-S checkpoints after irradiation but impaired activation of the "early" G(2)/M checkpoint. Together these results indicate a novel class of RS-SCID patients characterized by the specific absence of T lymphocytes and associated with defects in G(2)-specific DSB repair. The pronounced G(2)/M radiosensitivity of the RS-SCID patient described here, suggests a defect in a putative novel and uncharacterized factor involved in cellular DNA damage responses and T cell development.


Subject(s)
Cell Division/radiation effects , G2 Phase/radiation effects , Radiation Tolerance/genetics , Severe Combined Immunodeficiency/genetics , Cell Line , DNA Damage , Gene Rearrangement , Humans , T-Lymphocytes/metabolism , VDJ Recombinases/genetics , VDJ Recombinases/metabolism
19.
Cancer Lett ; 287(1): 67-74, 2010 Jan 01.
Article in English | MEDLINE | ID: mdl-19553004

ABSTRACT

A newly developed assay based on chemically induced premature chromosome condensation (PCC) and multi-color combined binary ratio labeling (COBRA) fluorescence in situ hybridization (FISH) techniques have been implemented in order to investigate for the first time for recurrent cytogenetic aberrations in primary cervical carcinoma (derived directly from biopsies) at different stages of progression. The cytogenetic profiles of 17 biopsies derived from 14 and 3 cervical cancer patients with squamous-cell carcinomas (Sq) and with adenocarcinomas (Ad), respectively, were assessed. Frequencies of both structural as well as numerical aberrations were found to be higher in Sq than in Ad. The analysis revealed that even in early tumors stages (IB1) have a higher frequency of chromosome-losses and -gains as well as chromosomal alterations as compared to normal cells. A positive trend was found between stage advancement of cervical tumors and the frequency of numerical and structural aberrations. No specific and common chromosomal abnormality (e.g. distinct clones of translocation) was found among cervical carcinoma at the different stages (IB1, IIA and IIB). However, a distinct difference was found between stage IIIB and lower tumor stages, as all analyzed IIIB samples revealed a near tetraploid karyotype. Furthermore, all studied metaphases were aberrant and had a high frequency of translocations. PCC-COBRA-FISH characterization of a common type of an established culture from cervical carcinoma CSCC-1 revealed a triploidy/tetraploidy karyotype with several structural aberrations. In general, no similarity was found between this model and early stages of primary tumors. The newly established assay has a novel potential and can reveal the original status of primary tumors at different stages.


Subject(s)
Adenocarcinoma/genetics , Carcinoma, Squamous Cell/genetics , Chromosome Aberrations , Chromosomes, Human/metabolism , In Situ Hybridization, Fluorescence/methods , Uterine Cervical Neoplasms/genetics , Cell Line, Tumor , Female , Humans , Karyotyping , Neoplasm Staging , Uterine Cervical Neoplasms/pathology
20.
PLoS One ; 4(9): e6936, 2009 Sep 07.
Article in English | MEDLINE | ID: mdl-19738907

ABSTRACT

Cohesion between sister chromatids is essential for faithful chromosome segregation. In budding yeast, the acetyltransferase Eco1/Ctf7 establishes cohesion during DNA replication in S phase and in response to DNA double strand breaks in G2/M phase. In humans two Eco1 orthologs exist: ESCO1 and ESCO2. Both proteins are required for proper sister chromatid cohesion, but their exact function is unclear at present. Since ESCO2 has been identified as the gene defective in the rare autosomal recessive cohesinopathy Roberts syndrome (RBS), cells from RBS patients can be used to elucidate the role of ESCO2. We investigated for the first time RBS cells in comparison to isogenic controls that stably express V5- or GFP-tagged ESCO2. We show that the sister chromatid cohesion defect in the transfected cell lines is rescued and suggest that ESCO2 is regulated by proteasomal degradation in a cell cycle-dependent manner. In comparison to the corrected cells RBS cells were hypersensitive to the DNA-damaging agents mitomycin C, camptothecin and etoposide, while no particular sensitivity to UV, ionizing radiation, hydroxyurea or aphidicolin was found. The cohesion defect of RBS cells and their hypersensitivity to DNA-damaging agents were not corrected by a patient-derived ESCO2 acetyltransferase mutant (W539G), indicating that the acetyltransferase activity of ESCO2 is essential for its function. In contrast to a previous study on cells from patients with Cornelia de Lange syndrome, another cohesinopathy, RBS cells failed to exhibit excessive chromosome aberrations after irradiation in G2 phase of the cell cycle. Our results point at an S phase-specific role for ESCO2 in the maintenance of genome stability.


Subject(s)
Acetyltransferases/metabolism , Chromosomal Proteins, Non-Histone/metabolism , Fibroblasts/metabolism , Growth Disorders/diagnosis , Camptothecin/pharmacology , Cell Cycle Proteins/metabolism , Chromosome Aberrations , Chromosome Segregation , Congenital Abnormalities/diagnosis , Congenital Abnormalities/genetics , DNA Damage , Etoposide/pharmacology , Growth Disorders/genetics , Humans , Infant , Male , Mitomycin/pharmacology , Nucleic Acid Synthesis Inhibitors/pharmacology , Sister Chromatid Exchange , Syndrome , Cohesins
SELECTION OF CITATIONS
SEARCH DETAIL
...